1.215

1.25% +0.015

Biotricity Inc (BTCY)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Biotricity Inc stock is currently priced at $1.215, with a 24-hour trading volume of 9,992. It has seen a +1.25% increased in the last 24 hours and a +1.25% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $1.21 pivot point. If it approaches the $1.22 resistance level, significant changes may occur.

Previous Close:

$1.20

Open:

$1.21

24h Volume:

9,992

Market Cap:

$11.51M

Revenue:

$11.63M

Net Income/Loss:

$-14.58M

P/E Ratio:

-0.5836

EPS:

-2.082

Net Cash Flow:

$-7.41M

1W Performance:

-11.31%

1M Performance:

+1.25%

6M Performance:

+36.52%

1Y Performance:

+89.84%

1D Range:

$1.20

$1.215

52W Range:

$0.5511

$3.7837

Biotricity Inc Stock (BTCY) Company Profile

Name

Biotricity Inc

Sector

Healthcare (1211)

Industry

Medical Devices (160)

Phone

650 832 1626

Address

275 Shoreline Drive, Suite 150, Redwood City

Employee

Twitter

Next Earnings Date

2024-05-15

Latest SEC Filings

BTCY's Discussions on Twitter

Biotricity Inc Stock (BTCY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-07-22	Initiated	Lake Street	Buy
Nov-23-21	Initiated	H.C. Wainwright	Buy

Biotricity Inc Stock (BTCY) Latest News

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Biotricity (BTCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks Investment Research

Biotricity Inc Stock (BTCY) Financials Data

Biotricity Inc (BTCY) Revenue 2024

BTCY reported a revenue (TTM) of $11.63 million for the quarter ending December 31, 2023, a +28.55% rise year-over-year.

Biotricity Inc (BTCY) Net Income 2024

BTCY net income (TTM) was -$14.58 million for the quarter ending December 31, 2023, a +25.58% increase year-over-year.

Biotricity Inc (BTCY) Cash Flow 2024

BTCY recorded a free cash flow (TTM) of -$7.41 million for the quarter ending December 31, 2023, a +54.91% increase year-over-year.

Biotricity Inc (BTCY) Earnings per Share 2024

BTCY earnings per share (TTM) was -$1.751 for the quarter ending December 31, 2023, a +26.02% growth year-over-year.

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.